Barton P. Bandy, President and CEO at ReShape Lifesciences Inc. (RSLS), sold 11,309 shares at $0.96 ($11K) on 2022-06-01, disclosed to the SEC on 2022-06-06.
Open-market sale of $11k RSLS by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.95 | 8,610 | $8K | 75.9% |
| 2 | $0.96 | 2,699 | $3K | 24.1% |
| Total | $0.95 avg | 11,309 | $11K | 100% |
| Filing → |
| RSLS | SELL | 2022-05-12 | $9K | — | Filing → |
| RSLS | SELL | 2022-04-08 | $13K | — | Filing → |
| RSLS | SELL | 2022-03-02 | $7K | — | Filing → |